Sabeen Mekan

Equibles does not estimate personal net worth.

Get an email with a short summary when Zymeworks Inc. publishes a filing, an earnings call transcript or a press release.

Get ZYME alerts

About Sabeen Mekan

Zymeworks Inc. reported in an 8-K filed January 12, 2026 that Sabeen Mekan was appointed Senior Vice President and Chief Medical Officer, effective February 1, 2026. Zymeworks Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zymeworks Inc. includes Ali Tehrani (CEO), Kenneth Galbraith (CEO and CFO), Kristin Stafford (CFO) and 7 others.

“On January 6, 2026, the Company appointed Dr. Sabeen Mekan as Senior Vice President and Chief Medical Officer, effective February 1, 2026.”

Zymeworks Inc. Form 8-K, filed January 12, 2026 · Read the filing

Affiliation history

Zymeworks Inc. (ZYME)
Proxy statement

Current
Start not stated–present

Last confirmed October 26, 2026

Company network

Zymeworks Inc.

ZYME

Current role

Biotechnology · Healthcare

Leadership on record at Zymeworks Inc.

Ali Tehrani CEO
Kenneth Galbraith CEO, CFO
Kristin Stafford CFO
Leone Patterson CFO
Mark Hollywood COO
Scott Platshon CIO, Board Member
Paul Schneider General Counsel
Alessandra Cesano Board Member
Brian Cherry Board Member
Carlos Campoy Board Member

Recent activity

Executive change Appointed: Senior Vice President and Chief Medical Officer Zymeworks Inc. (ZYME)
2026-02-01